U 86983: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 131256 |
| CHEMBL ID | 321994 |
| SCHEMBL ID | 6362810 |
| MeSH ID | M0238157 |
| Synonym |
|---|
| u-86983 |
| CHEMBL321994 |
| u 86983 |
| 2-(4-morphinyl)-8-(3-pyridinylmethoxy)-4h-1-benzopyran-4-one |
| 4h-1-benzopyran-4-one, 2-(4-morphinyl)-8-(3-pyridinylmethoxy)- |
| 130736-65-1 |
| 2-(4-morpholinyl)-8-(3-pyridinylmethoxy)-4h-1-benzopyran-4-one |
| 2-morpholin-4-yl-8-(pyridin-3-ylmethoxy)chromen-4-one |
| SCHEMBL6362810 |
| DTXSID50156703 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID159058 | Inhibitory activity against human platelet phosphodiesterase 2 at 50 uM expressed as percent basal value | 2004 | Bioorganic & medicinal chemistry letters, Jun-07, Volume: 14, Issue:11 | PDE2 inhibition by the PI3 kinase inhibitor LY294002 and analogues. |
| AID261040 | Inhibition of PDE3A at 50 uM | 2006 | Bioorganic & medicinal chemistry letters, Feb-15, Volume: 16, Issue:4 | Analysis of anti-PDE3 activity of 2-morpholinochromone derivatives reveals multiple mechanisms of anti-platelet activity. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||